Improving the MVA vaccine potential by deleting the viral gene coding for the IL-18 binding protein.

Improving the MVA vaccine potential by deleting the viral gene coding for the IL-18 binding protein.

BACKGROUND: Modified Vaccinia Ankara (MVA) is an attenuated strain of Vaccinia virus (VACV) currently employed in many clinical trials against HIV/AIDS and other diseases. MVA still retains genes involved in host immune response evasion, enabling its optimization by removing some of them. The aim of...

Full description

Bibliographic Details
Main Authors: Juliana Falivene, María Paula Del Médico Zajac, María Fernanda Pascutti, Ana María Rodríguez, Cynthia Maeto, Beatriz Perdiguero, Carmen E Gómez, Mariano Esteban, Gabriela Calamante, María Magdalena Gherardi
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2012-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3285208?pdf=render

Internet

http://europepmc.org/articles/PMC3285208?pdf=render

Similar Items